Here is an excerpt from the Nextstellis launch announcement in Canada and a quote from Canadanian gynaecologist Dr. Amanda Black. It is the Dr. Black Zoom recording I am trying to track down........
Health Canada’s approval of Nextstellis® is based on two multinational, multicentre Phase 3 clinical studies of 3,725 women who were 16 to 50 years of age, and who had a Body Mass Index (BMI) up to 35kg/m2. Nextstellis® demonstrated contraceptive efficacy across all evaluated age and BMI ranges. The studies also demonstrated good bleeding profiles, cycle control, and tolerability, and with low rates of adverse reactions.
“Although contraceptive choice is improving for women in Canada, we still have more limited contraceptive choices compared to other developed countries,” said Dr. Amanda Black, MD, MPH, FRCSC, Professor of Obstetrics and Gynecology at The University of Ottawa. “For this reason, the approval of an additional novel contraceptive option in Canada is incredibly welcome. Beyond just having an additional choice that further empowers women, there is a lot of enthusiasm to introduce potentially safer contraceptives to the market, and Nextstellis® is one such product. An abundance of clinical safety data should be reassuring to physicians and patients alike.”
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)